(Stroke. 1997;28:1458-1460.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Neurology, Nihon University School of Medicine, Tokyo, Japan.
Correspondence to Yoko Mochizuki, MD, Department of Neurology, Nihon University Nerima Hikarigaoka Hospital, 2-11-1 Hikarigaoka, Nerima-ku, Tokyo 179, Japan. E-mail LEF00015{at}niftyserve.or.jp
| Abstract |
|---|
|
|
|---|
Methods Fifteen cases of lacunar infarction, 10 cases of multiple lacunar infarctions, and 16 control subjects were studied. Regional cerebral blood flow was measured within 14 days after stroke onset with the stable xenon CT method.
Results The rate of association of diabetes mellitus was higher in the multiple lacunar infarctions group than in the single lacunar infarction group. The blood flow in the cerebral cortex was significantly lower in the multiple lacunar infarctions group than in the single lacunar infarction group. The blood flow change by acetazolamide in the cerebral cortex was significantly lower in the multiple lacunar infarctions group than in the single lacunar infarction group.
Conclusions There is some difference in underlying diseases and cerebral blood flows between single and multiple lacunar infarctions.
Key Words: acetazolamide cerebral blood flow lacunar infarction xenon
| Introduction |
|---|
|
|
|---|
We investigated the difference in underlying diseases, cerebral blood flows, and cerebrovascular acetazolamide reactivity between the two types of lacunar infarction.
| Subjects and Methods |
|---|
|
|
|---|
|
Methods
Regional cerebral blood flow (rCBF) was measured within 14 days
after stroke onset with the stable xenon CT method.4 5 The
mean±SD time from onset of infarction until the rCBF examination was
6.0±4.7 days in the single lacunar infarction group and 7.6±4.5 days
in the multiple lacunar infarctions group. We examined two CT sections,
parallel to the orbitomeatal line, that showed cerebral infarction. A
gas mixture of 30% xenon and 50% oxygen was inhaled for 3 minutes,
followed by room air. For each section, CT scanning was performed once
before the xenon inhalation, 3 times during the xenon inhalation, and 5
times after the xenon inhalation. The picture analysis was
performed with AZ-7000 equipment (Anzai Medical). rCBF was
measured6 7 8 by placing the round ROI (region of interest)
on the cerebral cortex and cerebral white matter in the hemisphere
contralateral to the infarction, where there is no direct nerve fiber
connection with the infarct area (Fig 1
). The ROI in the
cerebral white matter was not placed on or near the
periventricular hyperintensity seen on MRI and was not
placed on the periventricular area, where the partial
volume effect may decrease accuracy. rCBF was measured before and 20
minutes after intravenous injection of 17 mg/kg
acetazolamide.
|
Statistical analysis was performed with the Mann-Whitney U test to compare data from various groups and with Fisher's exact probability tests for comparison of risk factors among the three groups.
| Results |
|---|
|
|
|---|
Fig 2
shows the actual records of xenon CT before
and after intravenous injection of
acetazolamide. Table 2
shows the mean±SD
values of rCBF and rCBF changes by acetazolamide. Before
the intravenous injection of acetazolamide,
rCBFs in the cerebral cortex and cerebral white matter were
significantly lower in the single and multiple lacunar infarctions
groups than in the control group. In addition, blood flow in the
cerebral cortex was significantly lower in the multiple lacunar
infarctions group than in the single lacunar infarction group. The
blood flow changes by acetazolamide in the cerebral cortex
and cerebral white matter were significantly less in the single and
multiple lacunar infarctions groups than in the control group. The
blood flow change by acetazolamide in the cerebral cortex
was significantly less in the multiple lacunar infarctions group than
in the single lacunar infarction group.
|
|
| Discussion |
|---|
|
|
|---|
rCBF may be reduced not only in infarcts and the ischemic penumbra but also in regions experiencing diaschisis.11 Xenon CT has an advantage in that rCBF measurements correspond closely to anatomic structures on CT.12 13 Because we measured blood flows in the cerebral cortex and cerebral white matter, where the influence of lacunar infarction is minimal, the influence of diaschisis was also minimal. Xenon CT with the wash-in/washout protocol has been reported to show considerable reliability in measuring blood flow in the cerebral white matter5 and has been used in patients with pathological conditions.6 7 8 Using the same instrument and the same method of xenon CT as ours, Haku et al14 reported a significant correlation (r=.68, P<.001) between rCBF values (10 to 30 mL/100 g per minute) of the white matter area obtained by xenon CT and those of 133Xe single-photon emission CT, which has been accepted as a standard method for the measurement of rCBF. Because the cerebral white matter blood flow in the present study is approximately 10 to 20 mL/100 g per minute in the patients, the blood flow values are considered reliable.
There was no significant difference in sex and age among the three groups, but the rate of association of hypertension was significantly higher in the single and multiple lacunar infarctions groups than in the control group in the present study; this is in agreement with a previous report.2
Our finding that the rate of association of diabetes mellitus was significantly higher in the multiple lacunar infarctions group than in the single lacunar infarction group is in accordance with the report15 that glucose intolerance occurred significantly more frequently in the group with silent lesions than in the group with CT evidence of acute stroke. Silent lacunar lesion on MRI in neurologically normal persons without a past history of cerebrovascular disease was reported to be closely related to decrease of cerebral circulation and may be an important risk factor for symptomatic cerebrovascular disease.16 rCBF was significantly lower in the multiple lacunar infarctions group than in the single lacunar infarction group in the present study as well.
Moreover, cerebrovascular acetazolamide reactivity in the cerebral cortex was significantly lower in the multiple lacunar infarctions group than in the single lacunar infarction group in the present study. Acetazolamide dilates cerebral arterioles by inhibiting carbonic anhydrase and increasing arteriolar CO217 18 and is useful for examining cerebrovascular dilatory reserve capacity.18 Acetazolamide may also be useful in identifying arteriosclerosis.19 The present study suggests that arteriosclerosis is more advanced in the multiple lacunar infarctions group than in the single lacunar infarction group. Boiten et al3 postulated a hypothesis that there are two clinically distinct lacunar infarct entities: (1) single lacunar infarction caused by microatheromatous disease and (2) multiple lacunar infarctions related to arteriolosclerosis. No report has examined the difference in cerebral blood flows between the two. The present study supports the hypothesis of Boiten et al.
Received January 21, 1997; revision received March 31, 1997; accepted April 8, 1997.
| References |
|---|
|
|
|---|
2.
Fisher CM. Lacunar strokes and infarcts: a
review. Neurology. 1982;32:871-876.
3.
Boiten J, Lodder J, Kessels F. Two clinically
distinct lacunar infarct entities? A hypothesis.
Stroke. 1993;24:652-656.
4. Johnson DW, Stringer WA, Marks MP, Yonas H, Good WF, Gur D. Stable xenon CT cerebral blood flow imaging: rationale for and role in clinical decision making. AJNR Am J Neuroradiol. 1991;12:201-213.[Abstract]
5. Kashiwagi S, Yamashita T, Nakano S, Kalender W, Polacin A, Takasago T, Eguchi Y, Ito H. The wash-in/washout protocol in stable xenon CT cerebral blood flow studies. AJNR Am J Neuroradiol. 1992;13:49-53.[Abstract]
6. Kawamura J, Terayama Y, Takashima S, Obara K, Pavol MA, Meyer JS, Mortel KF Weathers S. Leuko-araiosis and cerebral perfusion in normal aging. Exp Aging Res. 1993;19:225-240.[Medline] [Order article via Infotrieve]
7. Oishi M, Mochizuki Y, Hara M, Du C-M, Takasu T. Effects of intravenous L-dopa on P300 and regional cerebral blood flow in parkinsonism. Int J Neurosci.. 1996;85:147-154.[Medline] [Order article via Infotrieve]
8. Mochizuki Y, Oishi M, Hara M, Yoshihashi H, Takasu T. Regional cerebral blood flow in lacunar infarction. J Stroke Cerebrovasc Dis. 1997;6:137-140.
9.
Awad IA, Johnson PC, Spetzler RF, Hodak JA.
Incidental subcortical lesions identified on magnetic resonance imaging
in the elderly, II: postmortem pathological correlations.
Stroke. 1986;17:1090-1097.
10. Kirkpatrick JB, Hayman LA. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis. Neuroradiology. 1987;162:509-511.
11.
Feeney DM, Baron JC. Diaschisis.
Stroke. 1986;17:817-830.
12.
Yonas H, Gur D, Claassen D, Wolfson SK Jr, Moossy
J. Stable xenon enhanced computed tomography in the study of
clinical and pathologic correlates of focal ischemia in
baboons. Stroke. 1988;19:228-238.
13. Holl K, Nemati N, Heissler H, Gaab M, Haubitz B, Becker H, Dietz H. Chronic cerebrovascular insufficiency on the xenon CT scan. Neurosurg Rev. 1989;12:205-210.[Medline] [Order article via Infotrieve]
14. Haku T, Hosoya T, Komatani A, Watanabe N, Yamaguchi K. Correlation of regional cerebral blood flow between Xe-CT and 133Xe-SPECT: validity of Xe-CT in evaluating rCBF [in Japanese with English abstract]. Nippon Acta Radiol. 1996;56:828-833.
15.
Kase CS, Wolf PA, Chodosh EH, Zacker HB, Kelly-Hayes M,
Kannel WB, D'Agostino RB, Scampini L. Prevalence of silent
stroke in patients presenting with initial stroke: the Framingham
study. Stroke. 1989;20:850-852.
16.
Kobayashi S, Okada K, Yamashita K. Incidence of
silent lacunar lesion in normal adults and its relation to cerebral
blood flow and risk factors. Stroke. 1991;22:1379-1383.
17. Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest. 1984;74:1634-1639.
18.
Frankel HM, Garcia E, Malik F, Weiss JK, Weiss
HR. Effect of acetazolamide on cerebral blood flow
and capillary patency. J Appl Physiol. 1992;73:1756-1761.
19. Ringelstein EB, Eyck SV, Mertens I. Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide. J Cereb Blood Flow Metab. 1992;12:162-168.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
G. de Jong, F. Kessels, and J. Lodder Two Types of Lacunar Infarcts: Further Arguments From a Study on Prognosis Stroke, August 1, 2002; 33(8): 2072 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Hassan, A Lansbury, A J Catto, A Guthrie, J Spencer, C Craven, P J Grant, and J M Bamford Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 343 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Capizzano, N. Schuff, D. L. Amend, J. L. Tanabe, D. Norman, A. A. Maudsley, W. Jagust, H. C. Chui, G. Fein, M. R. Segal, et al. Subcortical Ischemic Vascular Dementia: Assessment with Quantitative MR Imaging and 1H MR Spectroscopy AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 621 - 630. [Abstract] [Full Text] |
||||
![]() |
C. Terborg, F. Gora, C. Weiller, and J. Rother Reduced Vasomotor Reactivity in Cerebral Microangiopathy : A Study With Near-Infrared Spectroscopy and Transcranial Doppler Sonography Stroke, April 1, 2000; 31(4): 924 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Inzitari, M. Eliasziw, B. L. Sharpe, A. J. Fox, and H. J. M. Barnett Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke Neurology, February 8, 2000; 54(3): 660 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Molina, J. A. Sabin, J. Montaner, A. Rovira, S. Abilleira, and A. Codina Impaired Cerebrovascular Reactivity as a Risk Marker for First-Ever Lacunar Infarction : A Case-Control Study Stroke, November 1, 1999; 30 (11): 2296 - 2301. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |